158 related articles for article (PubMed ID: 8398063)
1. The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck.
Field JK; Pavelic ZP; Spandidos DA; Stambrook PJ; Jones AS; Gluckman JL
Arch Otolaryngol Head Neck Surg; 1993 Oct; 119(10):1118-22. PubMed ID: 8398063
[TBL] [Abstract][Full Text] [Related]
2. p53 expression and mutations in squamous cell carcinoma of the head and neck: expression correlates with the patients' use of tobacco and alcohol.
Field JK; Zoumpourlis V; Spandidos DA; Jones AS
Cancer Detect Prev; 1994; 18(3):197-208. PubMed ID: 8076382
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of p53 in head and neck cancer.
Watling DL; Gown AM; Coltrera MD
Head Neck; 1992; 14(6):437-44. PubMed ID: 1468914
[TBL] [Abstract][Full Text] [Related]
4. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck.
Brennan JA; Boyle JO; Koch WM; Goodman SN; Hruban RH; Eby YJ; Couch MJ; Forastiere AA; Sidransky D
N Engl J Med; 1995 Mar; 332(11):712-7. PubMed ID: 7854378
[TBL] [Abstract][Full Text] [Related]
5. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
Haraf DJ; Nodzenski E; Brachman D; Mick R; Montag A; Graves D; Vokes EE; Weichselbaum RR
Clin Cancer Res; 1996 Apr; 2(4):755-62. PubMed ID: 9816227
[TBL] [Abstract][Full Text] [Related]
6. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
[TBL] [Abstract][Full Text] [Related]
7. P53 overexpression in epidermoid carcinoma of the head and neck.
Logullo AF; Kowalski LP; Nonogaki S; Miguel RE; Torloni H; Brentani RR
Sao Paulo Med J; 1997; 115(1):1349-55. PubMed ID: 9293116
[TBL] [Abstract][Full Text] [Related]
8. [High incidence of p53 mutations in primary and metastatic head and neck tumors. Frequent protein overexpression in normal epithelium].
Fogel S; Ahomadegbe JC; Barrois M; Le Bihan ML; Douc-Rasy S; Duvillard P; Armand JP; Riou G
Bull Cancer; 1996 Mar; 83(3):227-33. PubMed ID: 8695925
[TBL] [Abstract][Full Text] [Related]
9. p53 gene mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: a long-term follow-up study.
Riethdorf S; Friedrich RE; Ostwald C; Barten M; Gogacz P; Gundlach KK; Schlechte H; Becker J; Bregenzer T; Riethdorf L; Löning T
J Oral Pathol Med; 1997 Aug; 26(7):315-21. PubMed ID: 9250931
[TBL] [Abstract][Full Text] [Related]
10. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
[TBL] [Abstract][Full Text] [Related]
11. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
[TBL] [Abstract][Full Text] [Related]
12. The role of p53 tumor suppressor gene in human head and neck tumorigenesis.
Pavelic ZP; Gluckman JL
Acta Otolaryngol Suppl; 1997; 527():21-4. PubMed ID: 9197475
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment p53 protein expression correlates with decreased survival in patients with end-stage head and neck cancer.
Sauter ER; Ridge JA; Litwin S; Langer CJ
Clin Cancer Res; 1995 Nov; 1(11):1407-12. PubMed ID: 9815938
[TBL] [Abstract][Full Text] [Related]
14. Genetic instabilities of chromosome 9, 17 and accumulation of p53 overexpression during multistage tumorigesis in head and neck cancer.
Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S104-12. PubMed ID: 9071074
[TBL] [Abstract][Full Text] [Related]
15. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
[TBL] [Abstract][Full Text] [Related]
16. p53 mutation is rare in oral mucosa brushings from patients previously treated for a head and neck squamous cell carcinoma.
Acha-Sagredo A; Ruesga MT; Rodriguez C; Aguirregaviria JI; de Pancorbo MM; Califano JA; Aguirre JM
Oral Oncol; 2009 Aug; 45(8):661-4. PubMed ID: 19027352
[TBL] [Abstract][Full Text] [Related]
17. Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck.
Field JK; Spandidos DA; Malliri A; Gosney JR; Yiagnisis M; Stell PM
Br J Cancer; 1991 Sep; 64(3):573-7. PubMed ID: 1911200
[TBL] [Abstract][Full Text] [Related]
18. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma.
Koch WM; Brennan JA; Zahurak M; Goodman SN; Westra WH; Schwab D; Yoo GH; Lee DJ; Forastiere AA; Sidransky D
J Natl Cancer Inst; 1996 Nov; 88(21):1580-6. PubMed ID: 8901856
[TBL] [Abstract][Full Text] [Related]
19. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers.
Kropveld A; Rozemuller EH; Leppers FG; Scheidel KC; de Weger RA; Koole R; Hordijk GJ; Slootweg PJ; Tilanus MG
Lab Invest; 1999 Mar; 79(3):347-53. PubMed ID: 10092071
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer.
Edström S; Cvetkovska E; Westin T; Young C
Laryngoscope; 2001 Jan; 111(1):124-30. PubMed ID: 11192880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
